Hemostats Devices Medical Devices Pipeline Industry Assessment 2016
Wiseguyreports.com adds report on “Hemostats - Medical Devices Pipeline Assessment, 2016" provides an overview of Hemostats currently in pipeline stage.
PUNE, INDIA, April 15, 2016 /EINPresswire.com/ -- The report “Hemostats - Medical Devices Pipeline Assessment, 2016" provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostats pipeline products.Access a Report Copy @ https://www.wiseguyreports.com/reports/hemostats-medical-devices-pipeline-assessment-2016 .
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Hemostats under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hemostats and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hemostats under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Purchase a 1-User License Copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=403226 .
Major Points in Table of Content
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Hemostats Overview 9
3 Products under Development 10
3.1 Hemostats - Pipeline Products by Stage of Development 10
3.2 Hemostats - Pipeline Products by Segment 11
3.3 Hemostats - Pipeline Products by Territory 12
3.4 Hemostats - Pipeline Products by Regulatory Path 13
3.5 Hemostats - Pipeline Products by Estimated Approval Date 14
3.6 Hemostats - Ongoing Clinical Trials 15
4 Hemostats - Pipeline Products under Development by Companies 16
4.1 Hemostats Companies - Pipeline Products by Stage of Development 16
4.2 Hemostats - Pipeline Products by Stage of Development 18
5 Hemostats Companies and Product Overview 20
5.1 3-D Matrix, Ltd. Company Overview 20
5.2 Advanced Medical Solutions Group plc Company Overview 23
5.3 Anika Therapeutics, Inc. Company Overview 31
5.4 Arch Therapeutics Inc. Company Overview 33
5.5 Argon Medical Devices Inc. Company Overview 37
5.6 Baxter International Inc. Company Overview 38
5.7 Beth Israel Deaconess Medical Center, Inc. Company Overview 43
5.8 Biomedica Management Corporation Company Overview 44
5.9 Biom'Up SAS Company Overview 48
5.10 Cellphire, Inc. Company Overview 49
5.11 Covalent Medical, Inc. (Inactive) Company Overview 52
5.12 Covalon Technologies Ltd. Company Overview 53
5.13 CryoLife, Inc. Company Overview 56
5.14 Endomedix Incorporated Company Overview 60
5.15 Entegrion, Inc. Company Overview 62
5.16 Ethicon, Inc. Company Overview 63
5.17 Floralis S.A.S. Company Overview 64
5.18 Gamma Therapeutics, Inc. Company Overview 65
5.19 Haemostatix Limited Company Overview 66
5.20 Hemostasis, LLC Company Overview 69
5.21 KeraNetics, LLC Company Overview 71
5.22 LifeBond Ltd. Company Overview 72
5.23 Remedium Technologies Inc. Company Overview 75
5.24 Rice University Company Overview 76
5.25 Samyang Biopharmaceuticals Corporation Company Overview 78
5.26 Sanofi Company Overview 80
5.27 Sea Run Holdings Inc. Company Overview 82
5.28 St Teresa Medical, Inc. Company Overview 83
5.29 Suneris Technologies, Inc. Company Overview 87
5.30 The Medicines Company Company Overview 88
5.31 Therus Corporation Company Overview 90
5.32 Xcede Technologies, Inc. Company Overview 91
6 Hemostats- Recent Developments 92
6.1 Feb 18, 2016: Genelife Enters into Licensing Agreement with 3-D Matrix Europe 92
6.2 Feb 17, 2016: Z-Medica Receives Expanded CE Mark for QuikClot 92
6.3 Jan 21, 2016: United Health Products Announces Optimal Government Services as UHP's Exclusive Government Distributor 92
6.4 Dec 16, 2015: Arch Therapeutics Receives Clearance to Initiate Clinical Trial in Europe 93
6.5 Dec 09, 2015: Arsenal Medical Secures Funding from U.S. Army to Advance ResQFoam Trauma Product through Regulatory Approval 93
6.6 Dec 04, 2015: Change in B. Braun Management Board 94
6.7 Dec 01, 2015: Arch Therapeutics Reports Significant Wound Healing Results in Pre-Clinical Safety Study with AC5 Surgical Hemostatic Device 94
6.8 Nov 17, 2015: CryoLife Announces Resolution of PerClot Litigation with Medafor 95
6.9 Oct 28, 2015: United Health Products' HemoStyp Now Available Through Henry Schein 95
6.10 Oct 22, 2015: CoAg Medical And Lou Ferrigno Announce StopsBleeding Product Launch 95
6.11 Oct 20, 2015: Vascular Solutions Reports Third Quarter Results-2015 96
6.12 Sep 08, 2015: Arch Therapeutics Obtains Additional Positive Safety Data for AC5 Surgical Hemostatic Device in Preclinical Toxicity Test of Sensitization 98
6.13 Aug 24, 2015: United Health Products Announces School Health as a Distributor 99
6.14 Aug 18, 2015: Dynasil Announces Xcede Technologies' Patent Application for Novel All-in-One Patch 99
6.15 Aug 05, 2015: LifeBond Raises USD27 Million in Series D Financing 99
Inquire for more information @ https://www.wiseguyreports.com/enquiry/hemostats-medical-devices-pipeline-assessment-2016
Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
16468459349
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
